Showing results (1-10 of 617) with videos related to
Sort By:
Pageof 62
The American Journal of Cardiology|November 20, 2019
Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular BenefitsSubodh VermaThe Canadian Journal of Cardiology|August 17, 2004
C-reactive protein incites atherosclerosisSubodh VermaCanadian Journal of Diabetes|December 29, 2019
Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes MellitusAbhinav Sharma, Subodh VermaClinical Chemistry|March 27, 2013
Evolving role of microparticles in the pathophysiology of endothelial dysfunctionFina Lovren, Subodh VermaThe Canadian Journal of Cardiology|January 15, 2021
When and How to Use Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction or Chronic Kidney DiseaseEileen O'Meara, Subodh Verma3 Biotech|September 10, 2019
A comprehensive analysis of the B3 superfamily identifies tissue-specific and stress-responsive genes in chickpea (<i>Cicer arietinum</i> L.)Subodh Verma, Sabhyata BhatiaFunctional & Integrative Genomics|December 19, 2018
Analysis of genes encoding seed storage proteins (SSPs) in chickpea (Cicer arietinum L.) reveals co-expressing transcription factors and a seed-specific promoterSubodh Verma, Sabhyata BhatiaAnnual Review of Physiology|November 16, 2020
Effects of SGLT2 Inhibitors on Kidney and Cardiovascular FunctionVolker Vallon, Subodh VermaClinical Science (London, England : 1979)|April 1, 2005
C-reactive protein and statins: IL-8 as a molecular link?Paul E Szmitko, Subodh VermaJournal of the Cardiometabolic Syndrome|August 7, 2007
C-reactive protein and the metabolic syndrome: useful addition to the cardiovascular risk profile?Paul E Szmitko, Subodh VermaPageof 62